Effect of high-dose methylprednisolone and G-CSF treatments on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: a pilot study

Pediatr Hematol Oncol. 1998 Nov-Dec;15(6):539-44. doi: 10.3109/08880019809018316.

Abstract

Treatment of neutropenia with corticosteroids and hemopoietic growth factors may cause alterations in the immune system. This study investigated and compared the effects of various regimens (HDMP, G-CSF, and G-CSF + HDMP) on total lymphocyte counts and subtypes in neutropenic patients with acute lymphoblastic leukemia. Lymphocyte subtypes were studied just prior to treatment and 1 week later. In the HDMP group, total lymphocyte counts and the numbers of CD3+, CD4+, CD8+, and CD19+ lymphocytes and monocytes increased, while the helper/suppressor lymphocyte ratio decreased. No significant changes were seen in lymphocyte subtypes in the G-CSF and G-CSF + HDMP groups, apart from an increase in total lymphocyte numbers. In the control group there was an increase in the number of CD3+ and CD8+ lymphocytes and a decrease in the helper/suppressor lymphocyte ratio. These results suggest that HDMP has an inducing, rather than a suppressive effect on all lymphocyte subtypes studied.

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage*
  • Antigens, CD
  • Child
  • Child, Preschool
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Humans
  • Immunophenotyping
  • Lymphocyte Subsets / drug effects*
  • Lymphocyte Subsets / immunology
  • Methylprednisolone / administration & dosage*
  • Neutropenia / blood
  • Neutropenia / drug therapy*
  • Neutropenia / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology

Substances

  • Anti-Inflammatory Agents
  • Antigens, CD
  • Granulocyte Colony-Stimulating Factor
  • Methylprednisolone